equine antiserum
/ Bharat Serums and Vaccines
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
October 14, 2022
PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
(clinicaltrials.gov)
- P1/2 | N=7 | Terminated | Sponsor: Bharat Serums and Vaccines Limited | N=160 ➔ 7 | Trial completion date: Sep 2022 ➔ May 2022 | Active, not recruiting ➔ Terminated; Closed as no eligible patient.
Enrollment change • Trial completion date • Trial termination • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
July 27, 2022
PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
(clinicaltrials.gov)
- P1/2 | N=160 | Active, not recruiting | Sponsor: Bharat Serums and Vaccines Limited | Recruiting ➔ Active, not recruiting | Trial primary completion date: Mar 2022 ➔ Aug 2022
Enrollment closed • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 20, 2021
PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
(clinicaltrials.gov)
- P1/2; N=160; Recruiting; Sponsor: Bharat Serums and Vaccines Limited; Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 08, 2021
PROTECT: Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
(clinicaltrials.gov)
- P1/2; N=160; Not yet recruiting; Sponsor: Bharat Serums and Vaccines Limited
New P1/2 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 4
Of
4
Go to page
1